Which older Brazilians will accept a COVID-19 vaccine? Cross-sectional evidence from the Brazilian Longitudinal Study of Aging (ELSI-Brazil).

James MacinkoBrayan V SeixasJuliana Vaz de Melo MambriniMaria Fernanda Furtado Lima E Costa

Published in: BMJ open (2021)

Most national COVID-19 immunisation strategies identify older individuals as among those prioritised for early vaccination, given their increased risk of more severe symptoms and complications of the disease. Because individual, disease-specific, and contextual factors were associated with vaccine acceptance, there is a clear need for multilevel and multichannel information and outreach campaigns to increase COVID-19 vaccine acceptance among vulnerable older populations.

Keyphrases

coronavirus disease
sars cov
community dwelling
physical activity
cross sectional
middle aged
respiratory syndrome coronavirus
risk factors
early onset
healthcare
depressive symptoms
social media
drug induced
colorectal cancer screening